A detailed history of Kg&L Capital Management,Llc transactions in Novo Nordisk A S stock. As of the latest transaction made, Kg&L Capital Management,Llc holds 3,863 shares of NVO stock, worth $337,510. This represents 0.15% of its overall portfolio holdings.

Number of Shares
3,863
Previous 4,087 5.48%
Holding current value
$337,510
Previous $583,000 21.27%
% of portfolio
0.15%
Previous 0.2%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$119.07 - $145.42 $26,671 - $32,574
-224 Reduced 5.48%
3,863 $459,000
Q2 2024

Jul 22, 2024

SELL
$122.71 - $146.91 $9,203 - $11,018
-75 Reduced 1.8%
4,087 $583,000
Q1 2024

Apr 25, 2024

BUY
$102.11 - $135.92 $124,267 - $165,414
1,217 Added 41.32%
4,162 $534,000
Q4 2023

Jan 23, 2024

BUY
$87.78 - $105.45 $1,667 - $2,003
19 Added 0.65%
2,945 $304,000
Q3 2023

Oct 19, 2023

BUY
$90.94 - $199.54 $134,227 - $294,521
1,476 Added 101.79%
2,926 $266,000
Q2 2023

Jul 20, 2023

BUY
$155.98 - $172.65 $1,559 - $1,726
10 Added 0.69%
1,450 $234,000
Q1 2023

Apr 19, 2023

SELL
$132.34 - $159.14 $25,541 - $30,714
-193 Reduced 11.82%
1,440 $229,000
Q4 2022

Jan 18, 2023

BUY
$102.55 - $135.33 $167,464 - $220,993
1,633 New
1,633 $0
Q2 2022

Jul 22, 2022

SELL
$103.24 - $121.81 $83,624 - $98,666
-810 Reduced 28.21%
2,061 $230,000
Q1 2022

Apr 22, 2022

SELL
$93.1 - $112.54 $22,064 - $26,671
-237 Reduced 7.63%
2,871 $319,000
Q3 2021

Oct 14, 2021

BUY
$84.42 - $106.62 $5,065 - $6,397
60 Added 1.97%
3,108 $298,000
Q2 2021

Jul 15, 2021

SELL
$67.66 - $84.76 $202 - $254
-3 Reduced 0.1%
3,048 $255,000
Q1 2021

Apr 14, 2021

SELL
$67.06 - $75.82 $5,364 - $6,065
-80 Reduced 2.56%
3,051 $206,000
Q4 2020

Jan 19, 2021

BUY
$63.89 - $73.8 $200,039 - $231,067
3,131 New
3,131 $218,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Kg&L Capital Management,Llc Portfolio

Follow Kg&L Capital Management,Llc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kg&L Capital Management,Llc, based on Form 13F filings with the SEC.

News

Stay updated on Kg&L Capital Management,Llc with notifications on news.